{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:15:54Z","timestamp":1772151354371,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,3]]},"DOI":"10.7759\/cureus.96013","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T17:16:52Z","timestamp":1762190212000},"source":"Crossref","is-referenced-by-count":1,"title":["Renal Toxicity of Rosuvastatin: A Case Report"],"prefix":"10.7759","author":[{"given":"Carl","family":"Schulze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Shye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2016.4709","article-title":"Statins-almost 30 years of use in the United States and still not quite there","volume":"2","author":"Harrington RA","year":"2017","unstructured":"Harrington RA. Statins-almost 30 years of use in the United States and still not quite there. JAMA Cardiol. 2017, 2:66. 10.1001\/jamacardio.2016.4709","journal-title":"JAMA Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","year":"2024","unstructured":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024, 105.S117-314. 10.1016\/j.kint.2023.10.018","journal-title":"Kidney Int"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.6515\/acs20160611a","article-title":"Statin therapy: review of safety and potential side effects","volume":"32","author":"Ramkumar S","year":"2016","unstructured":"Ramkumar S, Raghunath A, Raghunath S. Statin therapy: review of safety and potential side effects. Acta Cardiol Sin. 2016, 32:631-9. 10.6515\/acs20160611a","journal-title":"Acta Cardiol Sin"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2006.03.017","article-title":"An overview of statin-associated proteinuria","volume":"11","author":"Tiwari A","year":"2006","unstructured":"Tiwari A. An overview of statin-associated proteinuria. Drug Discov Today. 2006, 11:458-64. 10.1016\/j.drudis.2006.03.017","journal-title":"Drug Discov Today"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-673616513-6","article-title":"Dangers of rosuvastatin identified before and after FDA approval","volume":"363","author":"Wolfe SM","year":"2004","unstructured":"Wolfe SM. Dangers of rosuvastatin identified before and after FDA approval. Lancet. 2004, 363:2189-90. 10.1016\/S0140-673616513-6","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/kisup.2011.31","article-title":"Section 1: introduction and methodology","volume":"2","year":"2012","unstructured":"Section 1. introduction and methodology. Kidney Int Suppl (2011). 2012, 2:13-8. 10.1038\/kisup.2011.31","journal-title":"Kidney Int Suppl (2011)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2022.10.005","article-title":"Statin therapy may protect against acute kidney injury in patients hospitalized for interstitial SARS-CoV2 pneumonia","volume":"33","author":"Piani F","year":"2023","unstructured":"Piani F, Di Salvo E, Landolfo M, Saracino IM, Agnoletti D, Borghi C, Fiorini G. Statin therapy may protect against acute kidney injury in patients hospitalized for interstitial SARS-CoV2 pneumonia. Nutr Metab Cardiovasc Dis. 2023, 33:227-31. 10.1016\/j.numecd.2022.10.005","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1613681","article-title":"Preexisting statin therapy is not associated with reduced acute kidney injury following cardiac surgery: a retrospective analysis","volume":"16","author":"Wang J","year":"2025","unstructured":"Wang J, Huang C, Chen Y, Huang Y, Wu Z. Preexisting statin therapy is not associated with reduced acute kidney injury following cardiac surgery: a retrospective analysis. Front Pharmacol. 2025, 16:1613681. 10.3389\/fphar.2025.1613681","journal-title":"Front Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad640","article-title":"Mechanisms of rosuvastatin-related acute kidney injury following cardiac surgery: the STICS trial","volume":"45","author":"Wijesurendra RS","year":"2024","unstructured":"Wijesurendra RS, Sardell R, Jayaram R, et al.. Mechanisms of rosuvastatin-related acute kidney injury following cardiac surgery: the STICS trial. Eur Heart J. 2024, 45:629-31. 10.1093\/eurheartj\/ehad640","journal-title":"Eur Heart J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh474","article-title":"Renal tubular toxicity of HMG-CoA reductase inhibitors","volume":"19","author":"van Zyl-Smit R","year":"2004","unstructured":"van Zyl-Smit R, Firth JC, Duffield M, Marais AD. Renal tubular toxicity of HMG-CoA reductase inhibitors. Nephrol Dial Transplant. 2004, 19:3176-9. 10.1093\/ndt\/gfh474","journal-title":"Nephrol Dial Transplant"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2016.08.037","article-title":"Renal tubular toxicity associated with rosuvastatin therapy","volume":"69","author":"Ward FL","year":"2017","unstructured":"Ward FL, John R, Bargman JM, McQuillan RF. Renal tubular toxicity associated with rosuvastatin therapy. Am J Kidney Dis. 2017, 69:473-6. 10.1053\/j.ajkd.2016.08.037","journal-title":"Am J Kidney Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2032","article-title":"Use of multiple international healthcare databases for the detection of rare drug-associated outcomes: a pharmacoepidemiological programme comparing rosuvastatin with other marketed statins","volume":"19","author":"Garc\u00eda Rodr\u00edguez LA","year":"2010","unstructured":"Garc\u00eda Rodr\u00edguez LA, Herings R, Johansson S. Use of multiple international healthcare databases for the detection of rare drug-associated outcomes: a pharmacoepidemiological programme comparing rosuvastatin with other marketed statins. Pharmacoepidemiol Drug Saf. 2010, 19:1218-24. 10.1002\/pds.2032","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2022020135","article-title":"Association of rosuvastatin use with risk of hematuria and proteinuria","volume":"33","author":"Shin JI","year":"2022","unstructured":"Shin JI, Fine DM, Sang Y, et al.. Association of rosuvastatin use with risk of hematuria and proteinuria. J Am Soc Nephrol. 2022, 33:1767-77. 10.1681\/ASN.2022020135","journal-title":"J Am Soc Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013070758","article-title":"Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes","volume":"25","author":"Sabbisetti VS","year":"2014","unstructured":"Sabbisetti VS, Waikar SS, Antoine DJ, et al.. Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes. J Am Soc Nephrol. 2014, 25:2177-86. 10.1681\/ASN.2013070758","journal-title":"J Am Soc Nephrol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106083","article-title":"Differentiation of glomerular, tubular, and normal proteinuria: determinations of urinary excretion of beta-2-macroglobulin, albumin, and total protein","volume":"48","author":"Peterson PA","year":"1969","unstructured":"Peterson PA, Evrin PE, Bergg\u00e5rd I. Differentiation of glomerular, tubular, and normal proteinuria: determinations of urinary excretion of beta-2-macroglobulin, albumin, and total protein. J Clin Invest. 1969, 48:1189-98. 10.1172\/JCI106083","journal-title":"J Clin Invest"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr708","article-title":"The value of simultaneous measurements of urinary albumin and total protein in proteinuric patients","volume":"27","author":"Smith ER","year":"2012","unstructured":"Smith ER, Cai MM, McMahon LP, Wright DA, Holt SG. The value of simultaneous measurements of urinary albumin and total protein in proteinuric patients. Nephrol Dial Transplant. 2012, 27:1534-41. 10.1093\/ndt\/gfr708","journal-title":"Nephrol Dial Transplant"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmedc.2009.01.004","article-title":"Algorithms for assessing the probability of an adverse drug reaction","volume":"2","author":"Doherty MJ","year":"2009","unstructured":"Doherty MJ. Algorithms for assessing the probability of an adverse drug reaction. Respiratory Medicine CME. 2009, 2:63-7. 10.1016\/j.rmedc.2009.01.004","journal-title":"Respiratory Medicine CME"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/412667-renal-toxicity-of-rosuvastatin-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T17:16:53Z","timestamp":1762190213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/412667-renal-toxicity-of-rosuvastatin-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.96013","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,3]]}}}